Services | Synterex | Synterex In rare disease development, regulatory decision-making often hinges on limited, non-traditional data. Common challenges that arise in the rare disease space include small sample sizes, single-arm or ...

In rare diseases, the “n of 1” matters, and efficacy narratives help tell that story with clarity and impact. For more on #EfficacyNarratives in #RareDiseases, read our latest LinkedIn post: www.linkedin.com/feed/update/...

#ClinicalDevelopment #RegulatoryStrategy #OrphanDrugs